Geode Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $49.8K | Buy |
|
|||||
|
2023
Q3 | $37.2K | Buy |
|
|||||
|
2023
Q2 | $45.3K | Sell |
|
|||||
|
2023
Q1 | $154K | Hold |
|
|||||
|
2022
Q4 | $224K | Sell |
|
|||||
|
2022
Q3 | $278K | Buy |
|
|||||
|
2022
Q2 | $684K | Buy |
|
|||||
|
2022
Q1 | $738K | Hold |
|
|||||
|
2021
Q4 | $782K | Sell |
|
|||||
|
2021
Q3 | $1.29M | Buy |
|
|||||
|
2021
Q2 | $1.41M | Buy |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2020
Q4 | $270K | Buy |
|
|||||
|
2020
Q3 | $392K | Sell |
|
|||||
|
2020
Q2 | $357K | Buy |
|
|||||
|
2020
Q1 | $225K | Buy |
|
|||||
|
2019
Q4 | $441K | Buy |
|
|||||
|
2019
Q3 | $237K | Hold |
|
|||||
|
2019
Q2 | $438K | Buy |
|
|||||
|
2019
Q1 | $645K | Buy |
|
|||||
|
2018
Q4 | $677K | Buy |
|
|||||
|
2018
Q3 | $886K | Buy |
|
|||||
|
2018
Q2 | $598K | Buy |
|
|||||
|
2018
Q1 | $610K | Hold |
|
|||||
|
2017
Q4 | $768K | Hold |
|
|||||
|
2017
Q3 | $912K | Buy |
|
|||||
|
2017
Q2 | $640K | Buy |
|
|||||
|
2017
Q1 | $363K | Buy |
|
|||||
|
2016
Q4 | $188K | Hold |
|
|||||
|
2016
Q3 | $204K | Hold |
|
|||||
|
2016
Q2 | $167K | Buy |
|
|||||
|
2016
Q1 | $254 | Hold |
|
|||||
|
2015
Q4 | $224K | Hold |
|
|||||
|
2015
Q3 | $164K | Hold |
|
|||||
|
2015
Q2 | $174K | Hold |
|
|||||
|
2015
Q1 | $163K | Buy |
|
|||||
|
2014
Q4 | $219K | Hold |
|
|||||
|
2014
Q3 | $166K | Hold |
|
|||||
|
2014
Q2 | $170K | Buy |
|
|||||
|
2014
Q1 | $133K | Buy |
|